
Bioorganic and Medicinal Chemistry Letters p. 1867 - 1872 (1998)
Update date:2022-09-26
Topics:
Hulme, Christopher
Moriarty, Kevin
Miller, Bruce
Mathew, Rose
Ramanjulu, Mercy
Cox, Paul
Souness, John
Page, Ken M.
Uhl, Joanne
Travis, Jeffrey
Huang, Fu-Chih
Labaudiniere, Richard
Djuric, Stevan W.
This communication describes the synthesis and in vitro evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. The compounds described contain an indole moiety which replaces the 'rolipram- like' 3-methoxy-4-cyclopentoxy motif. Several of the compounds presented possess low nanomolar IC50's for PDEIV inhibition. In vivo activities determined from measurement of serum TNF-α levels in LPS challenged mice (mouse endotoxemia model) are also reported.
View MoreTai zhou world Pharm & Chem Co., Ltd
Contact:+86-576-85301198
Address:Rome 1001,wangjiang plaza,unti 2,jinshan east Road linhai,zhejiang,china
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Contact:86-371-86169316
Address:No.1,Shakou Road,Zhengzhou,China
Shanghai Haoyuan Chemexpress Co., Ltd.
website:https://www.chemexpress.com/
Contact:86-21-58950125
Address:No.3 Building, No.1999, Zhangheng Road, ZhangjiangHighTech Park, Shanghai, P.R.China,201203
Xi'an Unique Electronic and Chemical Co., Ltd.
Contact:+86-029-88238008
Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
Doi:10.1016/0584-8539(96)01680-7
(1996)Doi:10.1002/ardp.19973301205
(1997)Doi:10.3390/ijms20215481
(2019)Doi:10.1007/BF02253171
(1997)Doi:10.1039/DT9920002651
(1992)Doi:10.1055/s-1995-3887
(1995)